Growth of medical cannabis created need for further education
Established in 2020, the program is designed to educate students in all aspects of the cannabis industry and understanding of the pharmacological properties of cannabis.
Established in 2020, the program is designed to educate students in all aspects of the cannabis industry and understanding of the pharmacological properties of cannabis.
Two expert groups have recently recommended against medicinal cannabis for people suffering persistent non-cancer pain
From 1 November this year, a new cannabis exemption card will be available to protect medicinal cannabis patients from arrest and legal prosecution in the UK.
As the disease worsens, non-motor symptoms become increasingly common. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur.
The fact that cannabis has a strong medical and therapeutic potential is not new. Indeed, the question we should ask is not about if medical cannabis works: the key question is how to get the maximum therapeutic benefit from cannabis and what combination of cannabinoids is the most efficient.
The Scottish Medicines Consortium has announced that Epidyolex will be the first cannabis-based medicine to be approved for use on the NHS. The CBD-based drug is used to treat rare forms of treatment-resistant epilepsy in children.
Medical cannabis use has been widely recorded throughout the world, and history, for the treatment of a huge array of conditions. In the ancient world, there is evidence that preparations of the plant were used to treat a variety of ailments, including epilepsy, and as an anaesthetic.
Medical cannabis use has been widely recorded throughout the world, and history, for the treatment of a huge array of conditions. In the ancient world, there is evidence that preparations of the plant were used to treat a variety of ailments, including epilepsy, and as an anaesthetic.
n increasing number of patients with rheumatoid arthritis (RA) are using cannabis to treat their symptoms, although systematic studies regarding efficacy in RA are lacking. Within this review we will give an overview on the overall effects of cannabinoids in inflammation and why they might be useful in the treatment of RA.
Minnesota’s medical cannabis program is unique, in that it routinely collects patient-reported scores on symptoms. This article focuses on changes in symptom severity reported by patients with cancer during their first 4 months of program participation.